BALUMOREXTON

UNII:	NE3ZS9HSP2
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₀H₁₂F₆N₄O₄S
Preferred Substance Name:	BALUMOREXTON
InChIKey:	QYIMOBVUEGPQSO-CYBMUJFWSA-N
GSRS Full Record:	NE3ZS9HSP2 i

3037907-48-2
Balumorexton
Methanesulfonamide, N-[(6R)-7,7-difluoro-2-[5-fluoro-4-(2,4,6-trifluorophenyl)-1,2-benzisoxazol-3-yl]-2,5,6,7-tetrahydro-3-oxo-3H-pyrrolo[1,2-c]imidazol-6-yl]-
N-[(6R)-7,7-difluoro-2-[5-fluoro-4-(2,4,6-trifluorophenyl)-1,2-benzoxazol-3-yl]-3-oxo-5,6-dihydropyrrolo[1,2-c]imidazol-6-yl]methanesulfonamide
N-{(6R)-7,7-Difluoro-2-[5-fluoro-4-(2,4,6-trifluorophenyl)-1,2-benzoxazol-3-yl]-3-oxo-2,5,6,7-tetrahydro-3H-pyrrolo[1,2-c]imidazol-6-yl}methanesulfonamide
balumorexton [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

BALUMOREXTON

Synonyms and Mappings

Resources